Latest XGN reports update at 2024-05-13: 2024-Q12023-Q42023-Q1
Exagen  logo
Exagen XGN
$ 1.82 -1.62%

Exagen Balance Sheet 2011-2024 | XGN

Annual Balance Sheet Exagen

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-16.3 M -32.6 M -72 M -4.13 M -46 M 11.5 M 7.6 M - 23.4 M 13.9 M 1.17 M -150 K -

Long Term Debt

19.2 M 28.8 M 27.5 M 26.7 M 25.9 M 24.6 M 18.8 M - - - - 1.38 M -

Long Term Debt Current

976 K 1.04 M - - - - - - - - - - -

Total Non Current Liabilities

- - - 27.8 M 26.8 M 26.7 M 20 M - 1.89 M 4.94 M 5.42 M 4.05 M -

Total Current Liabilities

11.9 M 9.62 M 9.32 M 8.77 M 5.9 M - - - - - - - -

Total Liabilities

34.2 M 43.8 M 38.5 M 36.5 M 32.7 M 35.6 M 25 M - 36.8 M 31.2 M 16 M 6.44 M -

Deferred Revenue

- - - - - - - - - - - - -

Retained Earnings

-279 M -256 M -208 M -181 M -165 M -153 M -148 M - -108 M -89.3 M -74.3 M -60.8 M -

Total Assets

56.9 M 86.2 M 123 M 78.4 M 88.3 M 28.9 M 20.4 M - 14.6 M 17.1 M 16.5 M 11.3 M -

Cash and Cash Equivalents

36.5 M 62.4 M 99.4 M 57.4 M 72.1 M 13.3 M - - - - - - -

Book Value

22.7 M 42.5 M 84.9 M 41.8 M 55.7 M -6.73 M -4.64 M - -22.2 M -14.1 M 451 K 4.82 M -

Total Shareholders Equity

22.7 M 42.5 M 84.9 M 41.8 M 55.7 M -112 M - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Exagen

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

19.3 M 19.2 M 19.2 M 19.2 M 29.1 M 28.8 M 28 M - 27.7 M 27.5 M 27.3 M 27.1 M 26.9 M 26.7 M 26.7 M 26.7 M 26.7 M 25.9 M 25.9 M 25.9 M 25.9 M 24.6 M 24.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

30.8 M 34.2 M 33.4 M 32.3 M 43.3 M 43.8 M 45.4 M 44 M 45.9 M 38.5 M 37 M 36.9 M 36.1 M 36.5 M 36.5 M 36.5 M 36.5 M 32.7 M 32.7 M 32.7 M 32.7 M 35.6 M 35.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-283 M -279 M -274 M -268 M -263 M -256 M -241 M -233 M -218 M -208 M -201 M -194 M -187 M -181 M -181 M -181 M -181 M -165 M -165 M -165 M -165 M -153 M -153 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

50.8 M 56.9 M 60.9 M 64.2 M 79.2 M 86.2 M 102 M 107 M 122 M 123 M 128 M 133 M 138 M 78.4 M 78.4 M 78.4 M 78.4 M 88.3 M 88.3 M 88.3 M 88.3 M 28.9 M 28.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

27.3 M 36.5 M 28.4 M 31.5 M 52.4 M 62.4 M 68.9 M 76.5 M 89.8 M 99.4 M 107 M 113 M 118 M 57.4 M 57.4 M 57.4 M 57.4 M 72.1 M 72.1 M 72.1 M 72.1 M 13.2 M 13.2 M - - 11.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

20 M 22.7 M 27.5 M 31.9 M 35.9 M 42.5 M 56.2 M 62.8 M 76.2 M 84.9 M 90.8 M 96.4 M 101 M 41.8 M 41.8 M 41.8 M 41.8 M 55.7 M 55.7 M 55.7 M 55.7 M -6.73 M -6.73 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

20 M 22.7 M 27.5 M 31.9 M 35.9 M 42.5 M 56.2 M 62.8 M 76.2 M 84.9 M 90.8 M 96.4 M 101 M 41.8 M 41.8 M 41.8 M 41.8 M 55.7 M 55.7 M 55.7 M 55.7 M -112 M -112 M -103 M -98.9 M -96.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency